JACC: CardioOncology September 01, 2020 | Vol. 2 No. 3 – Table of Contents of this issue
ARTICLES IN THIS ISSUE (open access):
- STATE-OF-THE-ART REVIEW: Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance – Robert P. Giugliano, Eugene Braunwald, et. al.
- PRIMERS IN CARDIO-ONCOLOGY: Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies – June-Wha Rhee, Joseph C. Wu, et. al.
- ORIGINAL RESEARCH: Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT – Robert P. Giugliano, Eugene Braunwald, et. al.
- EDITORIAL COMMENT: IMPROVE-IT: A Final Closure to Carcinogenicity of Ezetimibe? – Eldrin F. Lewis and June-Wha Rhee
- ORIGINAL RESEARCH: Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease – Cilie C. van ’t Klooster, Frank L.J. Visseren, et. al.
- EDITORIAL COMMENT: Praise to Robust Prediction Modeling in Large Datasets – Ewout W. Steyerberg and Edouard F. Bonneville
- ORIGINAL RESEARCH: Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis – Richard K. Cheng, Mathew S. Maurer, et. al.
- EDITORIAL COMMENT: The Incremental Value of Diuretic Dose in Staging Systems for Transthyretin Cardiac Amyloid: Keep It Simple – Martha Grogan
- ORIGINAL RESEARCH: Direct Oral Anticoagulants in Patients With Active Cancer: A Systematic Review and Meta-Analysis – Jolanda Sabatino, Ciro Indolfi, et. al.
- EDITORIAL COMMENT: Evolving Treatment Options for Cancer-Related Venous Thromboembolism – Doaa Attia and Alok A. Khorana
- ORIGINAL RESEARCH: Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer – Alan C. Cameron, Ninian N. Lang, et. al.
- EDITORIAL COMMENT: Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer: Looking for Something Heavier Than Heavy Metal – Joerg Herrmann
- ORIGINAL RESEARCH: Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation -Richard J. Massey, Jan O. Beitnes, et. al.
- EDITORIAL COMMENT: Not So Young at Heart : Long-Term Cardiac Dysfunction in Young Adult Hematopoietic Cell Transplantation Survivors – Navneet S. Majhail and Neel S. Bhatt
- ORIGINAL RESEARCH: Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment – Zachary S. Clayton, Douglas R. Seals, et. al
- EDITORIAL COMMENT: Anthracycline-Induced Vascular Dysfunction: Is MitoQ the Answer? – Douglas B. Sawyer
- ORIGINAL RESEARCH: Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting – Melissa Y.Y. Moey, Blase A. Carabello, et. al.
- EDITORIAL COMMENT: Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time? – Mandar A. Aras, Javid J. Moslehi, et. al.
- RESEARCH LETTER: Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement – Vardhmaan Jain, Samir R. Kapadia, et. al.
- RESEARCH LETTER: Assessment of Cardiac Function in Chemotherapy Naive Women With Breast Cancer Undergoing Contemporary Radiation Therapy – Alexandra C. Murphy, Omar Farouque, et. al.
- CLINICAL CASE CHALLENGES: Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors – Mariana Mirabel, Laurent Andreoletti, et. al.
- CLINICAL CASE CHALLENGES: CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy – Anthony J. Kanelidis, Nir Uriel, et. al.
- CLINICAL CASE CHALLENGES: Multimodality Treatment for Advanced Cervical Cancer With Isolated Metastasis to Interventricular Septum of the Heart – Ayelet Shapira-Daniels, Oz M. Shapira, et. al.
- CLINICAL CASE CHALLENGES: Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia – Anantha Sriharsha Madgula, Agnes S. Kim, et. al.
- CLINICAL CASE CHALLENGES: Cardiovascular Prevention in Individuals at High Risk of Developing Cancer – Ohad Oren, Eric H. Yang, et. al.
- EDITOR’S PAGE: Reflections on Our Inaugural Year of JACC: CardioOncology, With Gratitude and Tireless Devotion – Bonnie Ky
- VIEWPOINT: Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps – Diego Sadler, Anita Arnold, et. al.
CATEGORY
FOCUS ON: ESC & JACCYEAR OF PUBLICATION 2020Cancer survivorsCardio-Oncology in generalAnthracycline cardiotoxicityImmunotherapy cardiotoxicityCardiotoxicity from radiotherapyCardiotoxicity and left ventricular dysfunctionCardiotoxicity and stem cell transplantationGeneralPreventionVTE THROMBOEMBOLISM AND CANCER
FOCUS ON: ESC & JACCYEAR OF PUBLICATION 2020Cancer survivorsCardio-Oncology in generalAnthracycline cardiotoxicityImmunotherapy cardiotoxicityCardiotoxicity from radiotherapyCardiotoxicity and left ventricular dysfunctionCardiotoxicity and stem cell transplantationGeneralPreventionVTE THROMBOEMBOLISM AND CANCER